X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES BIOCON LTD ALKEM LABORATORIES/
BIOCON LTD
 
P/E (TTM) x - 54.3 - View Chart
P/BV x 6.7 5.1 131.0% View Chart
Dividend Yield % 0.6 0.2 266.8%  

Financials

 ALKEM LABORATORIES   BIOCON LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
BIOCON LTD
Mar-17
ALKEM LABORATORIES/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,162 136.8%   
Low Rs1,232483 255.3%   
Sales per share (Unadj.) Rs417.5194.6 214.6%  
Earnings per share (Unadj.) Rs56.334.4 163.6%  
Cash flow per share (Unadj.) Rs64.748.3 134.1%  
Dividends per share (Unadj.) Rs12.701.00 1,270.0%  
Dividend yield (eoy) %0.90.1 740.3%  
Book value per share (Unadj.) Rs292.9241.9 121.1%  
Shares outstanding (eoy) m119.57200.00 59.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.2 80.0%   
Avg P/E ratio x25.123.9 104.8%  
P/CF ratio (eoy) x21.817.0 128.0%  
Price / Book Value ratio x4.83.4 141.7%  
Dividend payout %22.62.9 776.2%   
Avg Mkt Cap Rs m168,653164,440 102.6%   
No. of employees `000NA9.2 0.0%   
Total wages/salary Rs m9,1717,470 122.8%   
Avg. sales/employee Rs ThNM4,213.9-  
Avg. wages/employee Rs ThNM809.0-  
Avg. net profit/employee Rs ThNM745.2-  
INCOME DATA
Net Sales Rs m49,91538,911 128.3%  
Other income Rs m1,6451,571 104.7%   
Total revenues Rs m51,56140,482 127.4%   
Gross profit Rs m8,4829,795 86.6%  
Depreciation Rs m1,0062,772 36.3%   
Interest Rs m671260 257.9%   
Profit before tax Rs m8,4518,334 101.4%   
Minority Interest Rs m-114163 -69.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6061,616 99.4%   
Profit after tax Rs m6,7316,881 97.8%  
Gross profit margin %17.025.2 67.5%  
Effective tax rate %19.019.4 98.0%   
Net profit margin %13.517.7 76.3%  
BALANCE SHEET DATA
Current assets Rs m27,06240,477 66.9%   
Current liabilities Rs m15,32416,783 91.3%   
Net working cap to sales %23.560.9 38.6%  
Current ratio x1.82.4 73.2%  
Inventory Days Days6760 111.6%  
Debtors Days Days4183 49.8%  
Net fixed assets Rs m12,61045,073 28.0%   
Share capital Rs m2391,000 23.9%   
"Free" reserves Rs m34,49047,377 72.8%   
Net worth Rs m35,02748,377 72.4%   
Long term debt Rs m1,21221,082 5.7%   
Total assets Rs m54,38793,942 57.9%  
Interest coverage x13.633.1 41.2%   
Debt to equity ratio x00.4 7.9%  
Sales to assets ratio x0.90.4 221.6%   
Return on assets %13.67.6 179.0%  
Return on equity %19.214.2 135.1%  
Return on capital %24.912.6 197.2%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Exports (fob) Rs m6,461NA-   
Imports (cif) Rs m1,540NA-   
Fx inflow Rs m6,56312,988 50.5%   
Fx outflow Rs m3,0127,899 38.1%   
Net fx Rs m3,5525,089 69.8%   
CASH FLOW
From Operations Rs m7,2596,400 113.4%  
From Investments Rs m1,864-4,985 -37.4%  
From Financial Activity Rs m-9,273-1,775 522.4%  
Net Cashflow Rs m-150-473 31.7%  

Share Holding

Indian Promoters % 66.9 40.4 165.6%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 33.1 8.4 394.0%  
FIIs % 0.0 10.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 19.9 -  
Shareholders   68,381 109,995 62.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   WOCKHARDT LTD.  J.B.CHEMICALS  ORCHID PHARMA LTD  DIVIS LABORATORIES  FULFORD INDIA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Dull End to the Trading Day; Metal & Auto Stocks Fall(Closing)

Indian share markets continued to trade range-bound in the afternoon session amid mixed international markets. At the closing bell, the BSE Sensex closed higher by 27 points.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Of Falling Real Estate Prices, Dr Arvind Panagariya and the Art of Continuing to Suck Up(Vivek Kaul's Diary)

Nov 13, 2017

Dr Panagariya claims real estate prices have fallen 25 per cent post demonetisation; the official data doesn't show anything like that.

Your Last Chance to Trade ONLY the Best Stocks(Daily Profit Hunter)

Nov 11, 2017

Techno-Funda opportunities are knocking on your door. Are you ready to receive them?

When the Sherlock Holmes in Me Follows Super Investors...(The 5 Minute Wrapup)

Nov 11, 2017

This Super Investor has knack of spotting megatrends in India.

Why I am the Biggest India Equity Bull on Planet Earth!(The Honest Truth)

Nov 16, 2017

If you have a dream, dream big...about the level of BSE 30 index in 2050!

The Day Warren Buffett Lost All His Money(Smart Contrarian)

Nov 15, 2017

Buffett is still using the lessons he learnt that fateful day.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Nov 23, 2017 03:35 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - STERLING BIOTECH COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS